Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Viking Therapeutics (VKTX) over the last 11 years, with Q3 2025 value amounting to 0.3%.

  • Viking Therapeutics' Return on Assets fell 2000.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.17% for FY2024, which is 1500.0% up from last year.
  • Latest data reveals that Viking Therapeutics reported Return on Assets of 0.3% as of Q3 2025, which was down 2000.0% from 0.2% recorded in Q2 2025.
  • Viking Therapeutics' Return on Assets' 5-year high stood at 0.1% during Q2 2024, with a 5-year trough of 0.45% in Q1 2023.
  • Its 5-year average for Return on Assets is 0.24%, with a median of 0.23% in 2023.
  • Per our database at Business Quant, Viking Therapeutics' Return on Assets skyrocketed by 3100bps in 2024 and then plummeted by -2000bps in 2025.
  • Over the past 5 years, Viking Therapeutics' Return on Assets (Quarter) stood at 0.25% in 2021, then crashed by -62bps to 0.41% in 2022, then skyrocketed by 44bps to 0.23% in 2023, then surged by 48bps to 0.12% in 2024, then plummeted by -154bps to 0.3% in 2025.
  • Its Return on Assets stands at 0.3% for Q3 2025, versus 0.2% for Q2 2025 and 0.14% for Q1 2025.